Lyka Labs Financial Statements
Lyka Labs Balance Sheet
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 40.40 | (13) | 18.30 | (46) |
| Op profit growth | (637) | 93.10 | (47) | (116) |
| EBIT growth | (250) | 20.60 | (44) | (186) |
| Net profit growth | (81) | 991 | (68) | 212 |
| Profitability ratios (%) | ||||
| OPM | 22.80 | (6) | (2.70) | (5.90) |
| EBIT margin | 15 | (14) | (10) | (21) |
| Net profit margin | (13) | (99) | (7.80) | (29) |
| RoCE | 9.81 | (6.40) | (4.60) | (7.60) |
| RoNW | 14.90 | (100) | (2.90) | (9.80) |
| RoA | (2.20) | (11) | (0.90) | (2.60) |
| Per share ratios () | ||||
| EPS | (3.50) | (22) | -- | -- |
| Dividend per share | -- | -- | -- | -- |
| Cash EPS | (6.90) | (24) | (4.60) | (10) |
| Book value per share | (8.70) | (4.80) | 15.60 | 17.90 |
| Valuation ratios | ||||
| P/E | (7.40) | (0.60) | -- | -- |
| P/CEPS | (3.80) | (0.50) | (5.40) | (4.50) |
| P/B | (2.90) | (2.60) | 1.60 | 2.61 |
| EV/EBIDTA | 10.80 | (288) | 851 | (168) |
| Payout (%) | ||||
| Dividend payout | -- | -- | -- | -- |
| Tax payout | (31) | 2.59 | (64) | (4.70) |
| Liquidity ratios | ||||
| Debtor days | 35.40 | 67.40 | 90.60 | 152 |
| Inventory days | 23.40 | 40.80 | 46.90 | 74.60 |
| Creditor days | (94) | (121) | (122) | (193) |
| Leverage ratios | ||||
| Interest coverage | (0.50) | 0.43 | 0.99 | 1.33 |
| Net debt / equity | (6.20) | (9.50) | 2.14 | 2.17 |
| Net debt / op. profit | 7.85 | (36) | (49) | (31) |
| Cost breakup () | ||||
| Material costs | (44) | (58) | (55) | (49) |
| Employee costs | (17) | (23) | (21) | (28) |
| Other costs | (16) | (25) | (26) | (28) |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
| Revenue | 86.30 | 61.40 | 70.80 | 59.80 |
| yoy growth (%) | 40.40 | (13) | 18.30 | (46) |
| Raw materials | (38) | (36) | (39) | (29) |
| As % of sales | 44 | 58.30 | 55.40 | 49.10 |
| Employee costs | (15) | (14) | (15) | (17) |
| As % of sales | 16.90 | 22.60 | 20.70 | 28.40 |
| Other costs | (14) | (15) | (19) | (17) |
| As % of sales | 16.30 | 25.10 | 26.50 | 28.40 |
| Operating profit | 19.70 | (3.70) | (1.90) | (3.60) |
| OPM | 22.80 | (6) | (2.70) | (5.90) |
| Depreciation | (8.30) | (8) | (7.30) | (11) |
| Interest expense | (26) | (20) | (7.20) | (9.60) |
| Other income | 1.56 | 3.09 | 2.09 | 2.13 |
| Profit before tax | (13) | (29) | (14) | (22) |
| Taxes | 4.05 | (0.70) | 9.07 | 1.04 |
| Tax rate | (31) | 2.59 | (64) | (4.70) |
| Minorities and other | (1.50) | 2.08 | 0.80 | 1.73 |
| Adj. profit | (10) | (27) | (4.40) | (20) |
| Exceptional items | (1.10) | (33) | (1.10) | 2.24 |
| Net profit | (12) | (61) | (5.60) | (17) |
| yoy growth (%) | (81) | 991 | (68) | 212 |
| NPM | (13) | (99) | (7.80) | (29) |
- Switch to
-
Tabular DataGraph
| Y/e 31 Mar ( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
| Profit before tax | (13) | (29) | (14) | (22) |
| Depreciation | (8.30) | (8) | (7.30) | (11) |
| Tax paid | 4.05 | (0.70) | 9.07 | 1.04 |
| Working capital | (44) | (60) | (66) | (26) |
| Other operating items | -- | -- | -- | -- |
| Operating cashflow | (62) | (97) | (79) | (58) |
| Capital expenditure | (12) | (8) | 74.30 | (93) |
| Free cash flow | (73) | (105) | (4.30) | (151) |
| Equity raised | 43.50 | 75.40 | 71.10 | 75 |
| Investments | (5.50) | (5.50) | (5.50) | (0.10) |
| Debt financing/disposal | 108 | 85.50 | 87.10 | 10.40 |
| Dividends paid | -- | -- | -- | -- |
| Other items | -- | -- | -- | -- |
| Net in cash | 72 | 50 | 148 | (66) |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar ( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
| Equity capital | 28.70 | 28.70 | 28.90 | 28.90 |
| Preference capital | 0.71 | 0.64 | 0.90 | 0.87 |
| Reserves | (54) | (43) | 14.10 | 20.60 |
| Net worth | (25) | (14) | 43.90 | 50.30 |
| Minority interest | ||||
| Debt | 162 | 141 | 95.50 | 112 |
| Deferred tax liabilities (net) | -- | -- | 0.38 | 0.28 |
| Total liabilities | 137 | 126 | 143 | 166 |
| Fixed assets | 124 | 133 | 139 | 144 |
| Intangible assets | ||||
| Investments | 0.02 | 0.02 | 0.02 | 0.23 |
| Deferred tax asset (net) | 16.40 | 12.30 | 13.40 | 4.24 |
| Net working capital | (10) | (29) | (11) | 15 |
| Inventories | 4.31 | 6.73 | 7 | 11.20 |
| Inventory Days | 18.20 | 40 | 36.10 | 68.40 |
| Sundry debtors | 8.67 | 8.04 | 14.60 | 20.50 |
| Debtor days | 36.70 | 47.80 | 75.40 | 125 |
| Other current assets | 29.60 | 30.30 | 40.70 | 47 |
| Sundry creditors | (15) | (19) | (24) | (25) |
| Creditor days | 62.50 | 116 | 123 | 152 |
| Other current liabilities | (38) | (54) | (50) | (39) |
| Cash | 7.15 | 10.30 | 1.71 | 2.43 |
| Total assets | 137 | 126 | 143 | 166 |
- Switch to
-
ConsolidatedStandalone
| Particulars ( Rupees In Crores.) | Jun-2021 | Mar-2021 | Dec-2020 | Sep-2020 | Jun-2020 |
|---|---|---|---|---|---|
| Gross Sales | 49.40 | 24.30 | 26.80 | 17.50 | 17.70 |
| Excise Duty | -- | -- | -- | -- | -- |
| Net Sales | 49.40 | 24.30 | 26.80 | 17.50 | 17.70 |
| Other Operating Income | -- | -- | -- | -- | -- |
| Other Income | 0.47 | 0.55 | 0.70 | 0.36 | 0.36 |
| Total Income | 49.90 | 24.80 | 27.50 | 17.80 | 18.10 |
| Total Expenditure ** | 19.50 | 19.10 | 20.80 | 14.50 | 13.80 |
| PBIDT | 30.40 | 5.74 | 6.71 | 3.34 | 4.32 |
| Interest | 6.93 | 6.37 | 6.59 | 6.60 | 6.38 |
| PBDT | 23.40 | (0.60) | 0.12 | (3.30) | (2.10) |
| Depreciation | 2.13 | 2.02 | 2.12 | 2.11 | 2.08 |
| Minority Interest Before NP | (0.10) | 0.44 | 0.41 | 0.03 | 0.59 |
| Tax | -- | -- | -- | -- | -- |
| Deferred Tax | 1.83 | (4.20) | (0.10) | 0.36 | (0.10) |
| Reported Profit After Tax | 19.60 | 1.14 | (2.30) | (5.80) | (4.70) |
| Minority Interest After NP | -- | -- | -- | -- | -- |
| Net Profit after Minority Interest | 19.60 | 1.14 | (2.30) | (5.80) | (4.70) |
| Extra-ordinary Items | -- | (1.10) | -- | (0.50) | -- |
| Adjusted Profit After Extra-ordinary item | 19.60 | 2.19 | (2.30) | (5.30) | (4.70) |
| EPS (Unit Curr.) | 6.80 | 0.39 | (0.80) | (2) | (1.60) |
| Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
| Dividend (%) | -- | -- | -- | -- | -- |
| Equity | 28.70 | 28.70 | 28.70 | 28.70 | 28.70 |
| Public Shareholding (Number) | -- | -- | -- | -- | -- |
| Public Shareholding (%) | -- | -- | -- | -- | -- |
| Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| PBIDTM(%) | 61.40 | 23.70 | 25 | 19.10 | 24.40 |
| PBDTM(%) | 47.40 | (2.60) | 0.45 | (19) | (12) |
| PATM(%) | 39.50 | 4.70 | (8.50) | (33) | (26) |
QuickLinks for Lyka Labs Ltd.
